ACME LaboratoriesDHA:ACMELAB +0.37%82 OCF Margin % is 15.45% as of Mar. 2026, which is 52% above its 10-year median of 10.14. GuruFocus rates DHA:ACMELAB with a GF Score™ of 82/100 and a GF Value™ of BDT124.74 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 956 Drug Manufacturers companies, ACME Laboratories ranks better than 62.34% on this metric.
The historical rank and industry rank for ACME Laboratories's OCF Margin % or its related term are showing as below:
DHA:ACMELAB'
s OCF Margin % Range Over the Past 10 Years
Min: 4.67 Med: 10.14 Max: 12.96
Current: 13.74
During the past 9 years, the highest OCF Margin % of ACME Laboratories was 12.96%. The lowest was 4.67%. And the median was 10.14%.
DHA:ACMELAB's OCF Margin % is ranked better than 62.34% of 956
companies
in the Drug Manufacturers industry
Industry Median: 9.985
vs DHA:ACMELAB: 13.74
ACME Laboratories OCF Margin % Related Terms
ACME Laboratories OCF Margin % Historical Data
* Premium members only.
The historical data trend for ACME Laboratories's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:ACMELAB vs ZTS, UTHR, VTRS: OCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, ACME Laboratories's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ACME Laboratories OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, ACME Laboratories's OCF Margin % distribution charts can be found below:
* The bar in red indicates where ACME Laboratories's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ACME Laboratories (DHA:ACMELAB) has a OCF Margin % of 15.45% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ACME Laboratories and its competitors. This is 52% above median its historical median of 10.14. Over the past decade, ACME Laboratories' OCF Margin % has ranged from 4.67 to 12.96. According to the industry distribution chart, ACME Laboratories ranks #360 out of 956 companies in the Drug Manufacturers industry, placing it in the top 37.7%.
Is ACME Laboratories' OCF Margin % too high?
ACME Laboratories' current OCF Margin % of 15.45% is 52% above median its 10-year median of 10.14. Over the past 10 years, this metric has ranged from a low of 4.67 to a high of 12.96. The Drug Manufacturers industry median OCF Margin % is 9.99. ACME Laboratories' value of 15.45% is 54.7% above this industry median. Based on the distribution chart, ACME Laboratories ranks #360 out of 956 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, ACME Laboratories has a GF Score™ of 82/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ACME Laboratories' OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, ACME Laboratories ranks #360 out of 956 companies for OCF Margin %. This puts ACME Laboratories in the upper half of its industry. The industry median OCF Margin % is 9.99. ACME Laboratories' value of 15.45% is 54.7% above this benchmark. Historically, ACME Laboratories' own OCF Margin % has ranged from 4.67 to 12.96 over the past decade. While the company's 10-year median is 10.14 vs. the industry median of 9.99, ACME Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.99, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ACME Laboratories's current OCF Margin % of 15.45% is 54.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ACME Laboratories and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ACME Laboratories's current OCF Margin % is 15.45%, which is 52% above median its own 10-year median of 10.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ACME Laboratories stock overvalued right now?
Based on GuruFocus' analysis, ACME Laboratories (DHA:ACMELAB) is currently considered Possible Value Trap. The stock's GF Value™ is BDT124.74, compared to a current price of BDT81.30 — trading 34.8% below its estimated fair value. The current OCF Margin % is 15.45%, which is 52% above median its 10-year median of 10.14 and 54.7% above the Drug Manufacturers industry median of 9.99. ACME Laboratories' overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For ACME Laboratories (DHA:ACMELAB), the current OCF Margin % is 15.45% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ACME Laboratories (DHA:ACMELAB) Overvalued in 2026?
Based on GuruFocus' analysis, ACME Laboratories stock appears to be undervalued.
The current stock price of BDT81.30 is trading 34.8% below its estimated GF Value™ of BDT124.74.
GuruFocus considers ACME Laboratories to be Possible Value Trap.
Key valuation signals for DHA:ACMELAB:
OCF Margin %: 15.45% (52% above median its 10-year median of 10.14)
GF Value™: BDT124.74 vs. price of BDT81.30 (34.8% below fair value)
Industry Position: 54.7% above the Drug Manufacturers median (#360 of 956)
No single metric tells the full story. See the DHA:ACMELAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The Company is engaged in manufacturing, marketing, and distribution of generic pharmaceuticals formulation products which includes human drugs comprising dosages form like a tablet, capsule, dry syrup, cream, ointment, powder, injection, dry powder inhaler, metered dosage inhaler, suppository, eye and nasal drop, liquid, liquid in hard gelatine, Blow Fill Seal (BFS) products, sachet products; veterinary drugs comprising dosages form like bolus, liquid,injection, water-soluble powder, premix and herbal drugs comprising dosages form like liquid, capsule, tablet, cream. The products of the company are sold in domestic and international markets.
82GF Score
Get the complete analysis for DHA:ACMELAB
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:ACMELAB has been successfully added to your 
